AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Miconazole in South Africa
6 products registered with SAHPRA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ORAMICO GEL | 57/20.2.2/0035 | LeBasi Pharmaceuticals (Pty) Ltd | active | 4 Feb 2030 |
| DAK-O-GEL | 44/20.2.2/0932 | Janssen Pharmaceutica (Pty) Ltd | suspended | 7 Dec 2022 |
| GYNO-DAKTARIN VC* | G/18.6/61 | Janssen Pharmaceutica (Pty) Ltd | suspended | 8 Nov 2022 |
| VARI-MICONAZOLE 2 % M/M ORAL GEL | 36/20.2.2/0233 | BARRS PHARMACEUTICAL INDUSTRIES (PTY) LTD | active | 1 Jan 1900 |
| DAKTARIN 2% | L/20.2.2/183 | Johnson & Johnson (Pty) Ltd û East London | active | 1 Jan 1900 |
| OTILAN | 07/17.3/31 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
Miconazole — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Miconazole, of which 4 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Miconazole registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.